Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Priority to JOP/2005/0168ApriorityCriticalpatent/JO3480B1/en
Application grantedgrantedCritical
Publication of JO3480B1publicationCriticalpatent/JO3480B1/en
A medicament comprising , separately or together (A) glycopyrrolate, and (B) either a compound of formual I In free or salt sovate form, wherein W, RX.RY, R1.R2.R3.R4.R5.R6 and R7 have the meaning as indicated in the specification In free or salt or solvate form, where in X has the meaning as indicated in the specification for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, pharmaceutical compositions that contain(A) and (B) are also described
JOP/2005/0168A2005-10-302005-10-30Combinations of glycopyrrolate and beta2 adrenoceptor agonists
JO3480B1
(en)